When did Opus Genetics report Q4 2024 earnings?

Opus Genetics (IRD) reported Q4 2024 earnings on March 31, 2025 before market open.

What were Opus Genetics's Q4 2024 revenue and EPS?

Opus Genetics reported revenue of $4.3M and diluted EPS of $-1.27 for Q4 2024.

Did Opus Genetics beat estimates in Q4 2024?

Revenue beat the consensus estimate of $3.4M by $913.5K. EPS missed the consensus estimate of $-0.34 by $0.93.

Where can I find Opus Genetics's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001140361-25-011410) directly on SEC EDGAR. The filing index links above go to sec.gov.

Opus Genetics IRD Q4 2024 Annual earnings

Reported March 31, 2025 · Before market open

Revenue$4.3MBeat by $913.5K Diluted EPS-$1.27Miss by $0.93

Revenue estimate$3.4M

EPS estimate-$0.34

Next report

Aug 12, 2026 (in a month)

Revenue estimate$2.6M

EPS estimate-$0.15

Financials

Q4 2024

Income statement

See full

Revenue$4.3M+154%

Operating income-$38.0M-600%

Net income-$35.1M-633%

EPS (diluted)-$1.27-505%

Balance sheet

See full

Cash & equivalents$30.3M-40.0%

Total equity$6.7M-86.5%

Total assets$36.9M-31.7%

Cash flow

See full

Operating cash flow-$7.4M—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$37.57M—

P/S3.4×—

Profitability

See full

Operating margin-564.7%-634pp

Net margin-523.4%-589pp

Returns & leverage

See full

Return on equity-203.2%-229pp

Current ratio3.2×-10.1×

Versus estimates

Revenue

Q4 2025$3.9MBeat by $721.0K Q1 2026$2.2MMiss by $771.1K Q3 2025$3.1MBeat by $7.6K Q2 2025$2.9MMiss by $201.3K Q1 2025$4.4MBeat by $970.0K

Q4 2024$4.3MBeat by $913.5K

Diluted EPS

Q4 2025-$0.19Miss by $0.03 Q1 2026-$0.75Miss by $0.59 Q3 2025-$0.12Beat by $0.02 Q2 2025-$0.12Beat by $0.13 Q1 2025-$0.32Beat by $0.02

Q4 2024-$1.27Miss by $0.93

Ask the moment Opus Genetics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Opus Genetics report Q4 2024 earnings?: Opus Genetics (IRD) reported Q4 2024 earnings on March 31, 2025 before market open.
What were Opus Genetics's Q4 2024 revenue and EPS?: Opus Genetics reported revenue of $4.3M and diluted EPS of $-1.27 for Q4 2024.
Did Opus Genetics beat estimates in Q4 2024?: Revenue beat the consensus estimate of $3.4M by $913.5K. EPS missed the consensus estimate of $-0.34 by $0.93.
Where can I find Opus Genetics's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001140361-25-011410) directly on SEC EDGAR. The filing index links above go to sec.gov.